Browsing Tag
Wells Fargo Securities
3 posts
Anteris Technologies (ASX: AVR) stock up 9.6% as PARADIGM trial reaches first US patient enrolments
Edwards and Medtronic own TAVR. Anteris (ASX: AVR) wants in with DurAVR. First US PARADIGM patients enrolled, US$320m raised, and Medtronic is now a shareholder.
Medtronic invests in Anteris (ASX: AVR) to fund DurAVR trial and TAVR platform expansion
Anteris Technologies has raised USD 320M, including USD 90M from Medtronic, to fund its global DurAVR heart valve trial. Read what this means for TAVR competition.
Northern Oil and Gas and Vital Energy embark on $1.1bn Delaware Basin acquisition
Northern Oil and Gas, Inc. (NYSE: NOG) and Vital Energy, Inc. (NYSE: VTLE) have unveiled a joint acquisition…